Genomic Vision SA (GV.PA) stock: key figures, P/E, revenue and dividend

Health Care · France · ISIN FR0011799907

Price
1,269.50 EUR
Market cap
89.55 bn EUR
P/E (2022)
–
P/S (2022)
89,545.58
Dividend yield
0.00 %
Net margin
-600.00 %
Return on equity (ROE)
465.48 %
Return on assets (ROA)
-120.26 %

Genomic Vision SA financials

Fiscal year20212022
Revenue0.00 EUR1.00 m EUR
Gross profit-1.00 m EUR-1.00 m EUR
EBIT-4.00 m EUR-6.00 m EUR
Net income-4.00 m EUR-6.00 m EUR
Diluted EPS – continuing operations-0.10 EUR-0.10 EUR

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Genomic Vision SA

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company provides FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision S, an automated scanner that develops life science research applications of single DNA molecules analysis and delivers fluorescence imaging; FiberSmart, an analysis software for replication combing assays; and accessories, which include combicoverslips, disposable DNA reservoirs, coverslips stickers, and bench holders. It offers FiberProbes; HexaCard, a genomic vision molecular combing technology offering a streamline one-stop-shop solution for biomanufacturing industries; TeloSizer, a novel tool for measurements of physical telomere length that can be applied to various model organisms; and EasyComb, EasyScan, and EasyComb Plus services. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.09.2026. Details in the risk notice.

Genomic Vision SA stock (GV.PA): P/E, revenue, dividend | finmetric